Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
Submitted by
admin
on November 4, 2016 - 9:42am
Source:
Bloomberg
News Tags:
collusion
DOJ
generics
Sanofi
Eli Lilly
Merck
Novo Nordisk
Mylan Labs
drug pricing
Headline:
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
Do Not Allow Advertisers to Use My Personal information